4D Molecular Therapeutics, Inc. ($FDMT)
Filing Information
| Accession Number | 0001920738-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
19,698
Total Value
$132,624.44
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 814 | $4.14 | $3,369.96 | 9,431 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 5,752 | $6.49 | $37,330.48 | 15,183 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jun 30, 2026 | Sale | 6,566 | $14.00 | $91,924.00 | 8,617 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 814 | $0.00 | $0.00 | 62,971 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 5,752 | $0.00 | $0.00 | 3,543 | Direct | โ | View Details |